Viewing Study NCT05443568


Ignite Creation Date: 2025-12-24 @ 5:44 PM
Ignite Modification Date: 2025-12-28 @ 2:05 PM
Study NCT ID: NCT05443568
Status: COMPLETED
Last Update Posted: 2025-10-06
First Post: 2022-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Israel, as Part of Local Clinical Practice
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module